Acute issues in the pharmacotherapy of hand osteoarthritis

Acute issues in the pharmacotherapy of hand osteoarthritis

The article focuses on the review of a pharmacotherapeutic approach to the therapy of hand osteoarthritis (HO). Apart from non-steroid antiinflammatory drugs (NSAID), promising therapeutic means of HO therapy include steroid drugs, chondroitin sulfate (CS), glucosamine sulfate (GS), and vitamin D. T...

Full description

Bibliographic Details
Main Authors:	O. A. Gromova, I. Yu. Torshin, A. V. Naumov, L. V. Vasilyeva, Ye. F. Yevstratova, А. N. Gromov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2021-02-01
Series:	Фармакоэкономика
Subjects:	hand osteoarthritis steroid and non-steroid anti-inflammatory drugs chondroitin sulfate glucosamine sulfate chondroguard sustaguard arthro
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/458

Similar Items

On the safety of glucosamine sulfate in patients with insulin resistance
by: Olga A. Gromova, et al.
Published: (2019-04-01)

Hand osteoarthritis: pathogenesis, diagnosis, and approaches to therapy
by: N. A. Shostak, et al.
Published: (2019-10-01)

Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis?
by: A. M. Lila, et al.
Published: (2020-08-01)

Study of different pharmaceutical forms and pathogenic therapy regimen effectiveness for back and joint pain treatment in comorbid patients with osteoarthritis
by: Lyudmila V. Vasil'eva, et al.
Published: (2019-02-01)

Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system
by: I. Yu. Torshin, et al.
Published: (2020-04-01)

Chondroprotectors: A range of application in general somatic practice
by: O A Shavlovskaya
Published: (2017-05-01)

Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard
by: I. Yu. Torshin, et al.
Published: (2021-02-01)

Standardised Forms of Chondroitin Sulfate as a Pathogenetic Treatment of Osteoarthritis in the Context of Post-Genomic Studies
by: O. A. Gromova, et al.
Published: (2021-02-01)

Evaluation of the efficacy and safety of a combination of chondroitin sulfate and glucosamine sulfate for knee and hip osteoarthritis in real clinical practice
by: A. E. Karateev, et al.
Published: (2020-11-01)

The results of postgenomic analysis of a glucosamine sulfate molecule indicate the prospects of treatment for comorbidities
by: I. Yu. Torshin, et al.
Published: (2018-12-01)

SLOW-ACTING ANTI-ARTHROSIS MEDICATIONS FOR THE TREATMENT OF OSTEOARTHRITIS
by: M. S. SVETLOVA
Published: (2016-12-01)

Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
by: Andri M.T. Lubis, et al.
Published: (2017-04-01)

Showiness or efficiency: what to choose?
by: D.G. Rekalov, et al.
Published: (2013-08-01)

Molecular effects of chondroguard in osteoarthritis and herniated discs
by: A. M. Lila, et al.
Published: (2017-11-01)

CLINICAL AND SONOGRAPHIC ASSESSMENT OF SYNOVITIS ACTIVITY IN PATIENTS WITH KNEE OSTEOARTHRITIS DURING THERAPY
by: A. V. Petrov, et al.
Published: (2016-02-01)

Effectiveness of Glucosamine and Chondroitin Sulfate Combination in Patients with Primary Osteoarthritis
by: Laszlo IRSAY, et al.
Published: (2010-12-01)

The management of patients with osteoarthritis by a primary care physician: focus on efficacy and safety
by: M. S. Svetlova
Published: (2018-05-01)

The use of injectable chondroitin sulfate in combination with dosed physical exercise for the treatment of patients with hand osteoarthritis
by: L. V. Vasilyeva, et al.
Published: (2020-09-01)

A new look at back pain treatment in light of the latest ESCEO guidelines
by: O. A. Shavlovskaya, et al.
Published: (2020-12-01)

Chemoreactome analysis of the antithrombotic effects of glucosamine sulfate and nonsteroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2019-03-01)

CURRENT PHARMACOTHERAPY FOR KNEE OSTEOARTHRITIS: SPECIFIC FEATURES OF SYMPTOMATIC AND DISEASE MODIFYING EFFECTS. COMMUNICATION 1. SPECIFIC FEATURES OF THE SYMPTOMATIC EFFECTS OF CURRENT DRUGS TO TREAT KNEE OSTHEOARTHRITIS
by: E. S. Tsvetkova, et al.
Published: (2015-03-01)

The clinical status and treatment options for osteoarthritis in patients with frailty
by: A V Naumov, et al.
Published: (2019-12-01)

Use of Artra and Artra MSM Forte in osteoarthritis of the large joints and lowback pain
by: E. P. Sharapova, et al.
Published: (2019-06-01)

Combined chondroprotectors in the treatment of osteoartritis
by: L.V. Derymedvid, et al.
Published: (2018-02-01)

Treatment of osteoarthritis: A focus on nimesulide
by: G. R. Imametdinova, et al.
Published: (2017-04-01)

Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative-dystrophic diseases of the joints and spine: results of proteomic analysis
by: O. A. Gromova, et al.
Published: (2018-06-01)

The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
by: A. P. Rebrov, et al.
Published: (2016-01-01)

Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01)

Chronic pain in older people: focus on sarcopenia
by: A. V. Naumov, et al.
Published: (2019-08-01)

ON ROLE OF CHONDROPROTECTIVE AGENTS IN OSTEOARTHRITIS: ON THE WAY TO THE EVIDENCE-BASED MEDICINE
by: S. V. Jargin
Published: (2016-11-01)

Analysis of the Health and Budgetary Impact of Chondroitin Sulfate Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBs
by: Rubio-Terrés C, et al.
Published: (2020-09-01)

Treatment in patients with osteoarthritis at different sites: Place of slow-acting drugs
by: N. V. Chichasova, et al.
Published: (2015-06-01)

Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis
by: I. V. Sarvilina, et al.
Published: (2020-02-01)

Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
by: E. V. Zonova
Published: (2021-04-01)

Comparative clinical and economic analysis of the use of symptomatic slow-acting drugs containing glucosamine sulfate in patients with Stage II gonarthrosis during outpatient care
by: I. V. Sarvilina, et al.
Published: (2019-12-01)

Systematic analysis of the molecular pathophysiology of tenosynovitis: promise for using chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2020-04-01)

The effect of glucosamine, chondroitin and harpagophytum procumbens on femoral hyaline cartilage thickness in patients with knee osteoarthritis– An MRI versus ultrasonography study
by: Florentin A. Vreju, et al.
Published: (2019-05-01)

Knee osteoarthrosis: Clinical presentation, diagnosis, treatment
by: Vladimir Vasilyevich Badokin
Published: (2013-10-01)

Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
by: Vladimir Vasil'evich Badokin, et al.
Published: (2011-09-01)

Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
by: Vladimir Vasil'evich Badokin, et al.
Published: (2011-09-01)

Cannot write session to /tmp/vufind_sessions/sess_srujkvtgttr23mvc2ikgmq0k0f